Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1434.5000 -13.80 (-0.95%)
NSE Jan 14, 2026 15:31 PM
Volume: 1.8M
 

logo
Cipla Ltd.
31 Oct 2025
1434.50
-0.95%
buy
by Axis Direct
Target: 1700 | Upside : 18.5%
Axis Direct
We remain positive on the stock with a BUY rating and arrive at a TP of Rs 1,700/share.
 
Number of FII/FPI investors decreased from 1124 to 1085 in Sep 2025 qtr
More from Cipla Ltd.
Recommended
Market closes lower, amid foreign fund outflows & US tariff threats on Iranian trading partners
Trendlyne Marketwatch | 14 Jan 2026, 04:03PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026, 06:40PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022